Literature DB >> 22829011

Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.

Chihiro Kijima1, Toshiyuki Miyashita, Maiko Suzuki, Hidehiro Oka, Kiyotaka Fujii.   

Abstract

Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by developmental defects and tumorigenesis. The gene responsible for NBCCS is PTCH1. The development of meningioma in NBCCS patients is a rare event. Here, we report two cases of NBCCS in which meningiomas did develop. The first patient carried a germline mutation in one allele of PTCH1, c.290dupA (p.N97KfsX43). In addition, the meningioma sample carried a somatic mutation, c.307delG (p.Val103LeufsX15), in the other allele of the same gene, suggesting a second hit. This is the first case of NBCCS-associated meningioma explained by the standard two-hit hypothesis. The second patient had a germline nonsense mutation in the SUFU gene, c.550C>T (p.Q184X). SUFU is located downstream of PTCH1 in the sonic hedgehog signaling pathway. This is the second time a germline mutation in SUFU has been found to cause NBCCS. Together with the previous report describing three cases of non-NBCCS medulloblastoma carrying a germline mutation in this gene, individuals with a SUFU germline mutation are expected to have a markedly high risk of developing medulloblastoma and probably meningioma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829011     DOI: 10.1007/s10689-012-9548-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  32 in total

1.  Human homolog of patched, a candidate gene for the basal cell nevus syndrome.

Authors:  R L Johnson; A L Rothman; J Xie; L V Goodrich; J W Bare; J M Bonifas; A G Quinn; R M Myers; D R Cox; E H Epstein; M P Scott
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

2.  Identification of a SUFU germline mutation in a family with Gorlin syndrome.

Authors:  L Pastorino; P Ghiorzo; S Nasti; L Battistuzzi; R Cusano; C Marzocchi; M L Garrè; M Clementi; G Bianchi Scarrà
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

3.  Meningiomas after medulloblastoma irradiation treatment in a patient with basal cell nevus syndrome.

Authors:  Ross M Campbell; Russell D Mader; Raymond G Dufresne
Journal:  J Am Acad Dermatol       Date:  2005-11       Impact factor: 11.527

4.  Basal cell naevus syndrome and intracranial meningioma.

Authors:  P S Mortimer; D P Geaney; K Liddell; R P Dawber
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

5.  Multiple intracranial meningiomas causing papilledema and visual loss in a patient with nevoid Basal cell carcinoma syndrome.

Authors:  Jonathan T Pribila; Shawn M Ronan; Jonathan D Trobe
Journal:  J Neuroophthalmol       Date:  2008-03       Impact factor: 3.042

Review 6.  Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.

Authors:  Seyed F A Amlashi; Laurent Riffaud; Gilles Brassier; Xavier Morandi
Journal:  Cancer       Date:  2003-08-01       Impact factor: 6.860

7.  Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

Authors:  H Hahn; C Wicking; P G Zaphiropoulous; M R Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; I Smyth; C Pressman; D J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; G Chenevix-Trench; B Wainwright; A E Bale
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  [Neurologic manifestations of basal cell nevomatosis. A case].

Authors:  O Aumaître; P Sampoux; A M Georget; J M Mondie; P Thieblot; G Dordain
Journal:  Presse Med       Date:  1986-11-29       Impact factor: 1.228

Review 10.  The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.

Authors:  D G Evans; P A Farndon; L D Burnell; H R Gattamaneni; J M Birch
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more
  24 in total

1.  Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.

Authors:  Léa Guerrini-Rousseau; Christelle Dufour; Pascale Varlet; Julien Masliah-Planchon; Franck Bourdeaut; Marine Guillaud-Bataille; Rachid Abbas; Anne-Isabelle Bertozzi; Fanny Fouyssac; Sophie Huybrechts; Stéphanie Puget; Brigitte Bressac-De Paillerets; Olivier Caron; Nicolas Sevenet; Marina Dimaria; Sophie Villebasse; Olivier Delattre; Dominique Valteau-Couanet; Jacques Grill; Laurence Brugières
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

2.  Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome.

Authors:  Katsunori Fujii; Hirofumi Ohashi; Maiko Suzuki; Hiromi Hatsuse; Tadashi Shiohama; Hideki Uchikawa; Toshiyuki Miyashita
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

3.  Members of the Rusc protein family interact with Sufu and inhibit vertebrate Hedgehog signaling.

Authors:  Zhigang Jin; Tyler Schwend; Jia Fu; Zehua Bao; Jing Liang; Huimin Zhao; Wenyan Mei; Jing Yang
Journal:  Development       Date:  2016-09-15       Impact factor: 6.868

4.  Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.

Authors:  Hayley J Sharpe; Gregoire Pau; Gerrit J Dijkgraaf; Nicole Basset-Seguin; Zora Modrusan; Thomas Januario; Vickie Tsui; Alison B Durham; Andrzej A Dlugosz; Peter M Haverty; Richard Bourgon; Jean Y Tang; Kavita Y Sarin; Luc Dirix; David C Fisher; Charles M Rudin; Howard Sofen; Michael R Migden; Robert L Yauch; Frederic J de Sauvage
Journal:  Cancer Cell       Date:  2015-03-09       Impact factor: 31.743

Review 5.  The Hedgehog pathway: role in cell differentiation, polarity and proliferation.

Authors:  Yanfei Jia; Yunshan Wang; Jingwu Xie
Journal:  Arch Toxicol       Date:  2015-01-06       Impact factor: 5.153

6.  Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same.

Authors:  A J Huq; M Walsh; B Rajagopalan; M Finlay; A H Trainer; F Bonnet; N Sevenet; I M Winship
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

Review 7.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

Review 8.  An Overview of Autosomal Dominant Tumour Syndromes with Prominent Features in the Oral and Maxillofacial Region.

Authors:  Robert A Kennedy; Selvam Thavaraj; Salvador Diaz-Cano
Journal:  Head Neck Pathol       Date:  2017-01-21

9.  Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene.

Authors:  Chise Kato; Kentaro Fujii; Yuto Arai; Hiromi Hatsuse; Kazuaki Nagao; Yoshinaga Takayama; Kouzou Kameyama; Katsunori Fujii; Toshiyuki Miyashita
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

10.  Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome.

Authors:  Kirsty Mann; Jill Magee; Marine Guillaud-Bataille; Christophe Blondel; Brigitte Bressac-de Paillerets; Josie Yeatman; Ingrid Winship
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.